However, the association of anemia with TDF-based regimen in this study, despite its low cytotoxicity towards erythroid progenitor cells and its effectiveness in terms of viral suppression, CD4 response and reduced adverse events compared to AZT and d4T [34], is largely unexplained and needs further study. This evidence concerns the gene CD4 and anemia.